Short-term effectiveness of low-dose radioiodine ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer

Thyroid

Volumn 9, Issue 4, 1999, Pages 387-391

  Vermiglio, Francesco ^a,b   Violi, Maria Antonia ^a   Finocchiaro, Maria Daniela ^a   Baldari, Sergio ^a   Castagna, Maria Grazia ^a   Moleti, Mariacarla ^a   Mattina, Filiberto ^a   Lo Presti, Vincenzo Pio ^a   Bonanno, Nunzio ^a   Trimarchi, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; THYROGLOBULIN; THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; IODINE 131 UPTAKE TEST; LYMPH NODE METASTASIS; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; TUMOR DIFFERENTIATION; WHOLE BODY SCINTISCANNING;

EID: 0032967024     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.387     Document Type: Article

References (18)

1. AACE Clinical Practice Guidelines for the Management of Thyroid Carcinoma. Endocr Pract 1997; 3:60-71.
2. Vermiglio F, Finocchiaro MD, Lo Presti VP, La Torre N, Nucifora M, Trimarchi F 1989 Partial beneficial effects of the so called "silent iodine prophylaxis" on iodine deficiency disorders (IDD) in Northeastern Sicily endemia. J Endocrinol Invest 12:123-126.
3. Maxon HR, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, Smith H, Cummings D, Aden MD 1992 Radioiodine-131 therapy for well-differentiated thyroid cancer. A quantitative radiation dosimetric approach: Outcome and validation in 85 patients. J Nucl Med 33: 1132-1136.
4. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306.
5. Ramacciotti C, Preforius HT, Line BR, Goldman JM, Robbins J 1982 Ablation of nonmalignant thyroid remnants with low doses of radioactive iodine: concise communication. J Nucl Med 23:483-489.
6. 131I to ablate residual thyroid tissue following surgery for thyroid cancer. Radiology 137:773-774.
7. Siddiqui AR, Edmondson J, Wellman HN, Hamaker RC, Lingeman RE, Park HM, Johnston CC 1981 Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma. Clin Nucl Med 6:158-161.
8. 131I in the treatment of patients with differentiated thyroid cancer? Nucl Med Commun 17:199-207.
9. Leung SF, Law MW, Ho SK 1992 Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases. Br J Radiol 65:905-909.
10. De Groot LJ, Reilly M 1982 Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation. Ann Intern Med 96:51-53.
11. McCowen KD, Adler RA, Ghaed N, Verdon T, Hofeldt FD 1976 Low dose radioiodide thyroid ablation in post surgical patients with thyroid cancer. Am J Med 61:52-58.
12. Snyder J, Gorman C, Scanlon P 1983 Thyroid remnant ablation: questionable pursuit of an ill-defined goal. J Nucl Med 24:659-665.
13. Ramanna L, Waxman AD, Brachman MB, Tanasescu DE, Sensel N, Braunstein GD 1985 Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med 10:791-795.
14. Creutzig H 1987 High or low dose radioiodine ablation of thyroid remnants? Eur J Nucl Med 12:500-502.
15. Bal C, Padhy AK, Jana S, Pant GS, Basu AK 1996 Prospective randomized clinical trial to evaluate the optimal dose of 1311 for remnant ablation in patients with differentiated thyroid carcinoma. Cancer 77:2574-2580.
16. Muratet JP, Giraud P, Daver A, Minier JF, Gamelin E, Larra F 1997 Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma. J Nucl Med 38:1362-1368.
17. 131I. Nucl Med Commun 17:839-842.
18. Leger FA, Izembart M, Dagousset F, Barritault L, Baillet G, Chevalier A, Clerc J 1998 Decreased uptake of therapeutic dose of iodine-131 after 185 MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma. Eur J Nucl Med 25:242-248.